CD79A and type 2 diabetes mellitus: In the KEGG analysis, the top 10 active pathways in the high-risk group were allograft rejection, antigen processing and presentation, DNA replication, glycosaminoglycan biosynthesis keratan sulfate, graft versus host disease, the intestinal immune network for IgA production, maturity- onset diabetes of the young, natural killer cell- mediated cytotoxicity, regulation of autophagy, and type I diabetes mellitus (Figure 6).